Adage Capital Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,936,633	Closed	-$340M	–	968
2023 Q3	$340M	Sell	2,936,633 -57,973	-2%	-$6.23M	0.77%	18
2023 Q2	$308M	Buy	2,994,606 +435,694	+17%	+$46M	0.67%	21
2023 Q1	$279M	Buy	2,558,912 +1,015,212	+66%	+$112M	0.63%	20
2022 Q4	$176M	Buy	1,543,700 +537,457	+53%	+$44.6M	0.42%	37
2022 Q3	$62.3M	Buy	1,006,243 +888,743	+756%	+$62.1M	0.15%	155
2022 Q2	$9.37M	Sell	117,500 -262,500	-69%	-$24.9M	0.02%	689
2022 Q1	$40M	Buy	380,000 +230,000	+153%	+$22.4M	0.08%	274
2021 Q4	$16.2M	Sell	150,000 -1,755,000	-92%	-$191M	0.03%	553
2021 Q3	$209M	Sell	1,905,000 -345,000	-15%	-$35.8M	0.41%	49
2021 Q2	$211M	Buy	2,250,000 +650,000	+41%	+$59.8M	0.41%	45
2021 Q1	$147M	Sell	1,600,000 -850,000	-35%	-$71.7M	0.3%	70
2020 Q4	$179M	Sell	2,450,000 -1,240,772	-34%	-$92.2M	0.39%	46
2020 Q3	$287M	Buy	3,690,772 +434,823	+13%	+$29.9M	0.72%	17
2020 Q2	$181M	Buy	+3,255,949	New	+$139M	0.46%	39
2020 Q1	–	Sell	-1,000,000	Closed	-$36.2M	–	818
2019 Q4	$36.2M	Sell	1,000,000 -500,000	-33%	-$15.3M	0.09%	262
2019 Q3	$40.8M	Buy	1,500,000 +100,000	+7%	+$2.59M	0.1%	233
2019 Q2	$33.7M	Buy	1,400,000 +400,000	+40%	+$10.1M	0.08%	267
2019 Q1	$26.4M	Buy	1,000,000 +425,000	+74%	+$10.1M	0.07%	319
2018 Q4	$11.2M	Buy	+575,000	New	+$11.3M	0.03%	488
2014 Q2	–	Sell	-350,000	Closed	-$5.29M	–	766
2014 Q1	$5.29M	Buy	+350,000	New	+$3.95M	0.01%	583

Other funds holding HZNP